EPO Patents = 2

Forward Citations = 2

Loading Chart...

27 inventors (with patents filed for the assignee):

Tatsuhiko Kodama (4 out of 31 patents)

Motomu Kanai (4 out of 22 patents)

Akira Sugiyama (4 out of 79 patents)

4. Tsuyoshi Inoue (4 out of 95 patents)

5. Eiichi Mizohata (3 out of 3 patents)

6. Tomohiro Meshizuka (3 out of 3 patents)

7. Yohei Shimizu (3 out of 22 patents)

8. Hirofumi Doi (3 out of 16 patents)

9. Tatsuya Kawato (3 out of 3 patents)

10. Mari Takatsu (2 out of 2 patents)

11. Noriaki Takasu (2 out of 2 patents)

12. Masanobu Tsukagoshi (2 out of 3 patents)

13. Kenzo Yamatsugu (1 out of 5 patents)

14. Shinichi Banba (1 out of 19 patents)

15. Tsuneji Suzuki (1 out of 24 patents)

6 patents: Sort by Forward Citations

1. 12115223 - Conjugate of biotin-modified dimer and phthalocyanine dye (2024-10-15),

2. 11866457 - Clearing agent (2024-01-09),

3. 11442066 - Method for identifying drug-discovery target protein for development of antibody drug, and method for producing antibody against target protein (2022-09-13),

4. 11286285 - Modified biotin, streptavidin mutant, and usage of them (2022-03-29),

5. 11161884 - Modified biotin, streptavidin mutant, and usage of them (2021-11-02),

6. 9670255 - Modified biotin, mutant streptavidin, and use thereof (2017-06-06),

Savid Therapeutics Inc. is a biotechnology company focused on developing innovative therapies for various medical conditions. With a strong emphasis on research and development, Savid Therapeutics is dedicated to advancing healthcare with cutting-edge solutions. Their team of experts is committed to improving patient outcomes and quality of life through groundbreaking treatments. Visit their website to learn more about their pioneering work in the field of therapeutics.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

6 Patents

#2,467 in Tokyo

#5,983 in Japan

Tokyo, Japan

Savid Therapeutics Inc.